Characterization of the prostanoid TP receptor population in human nonpregnant myometrium

Journal of Pharmacology and Experimental Therapeutics

Volumn 279, Issue 1, 1996, Pages 262-270

  Senchyna, Michelle ^a   Crankshaw, D J ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

15 CYCLOPENTYL 14 OXO 13 AZA 16,17,18,19,20 PENTANORPINANE THROMBOXANE A2; 15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 6 [2 (2 CHLOROPHENYL) 4 (2 HYDROXYPHENYL) 1,3 DIOXAN 5 YL] 4 HEXENOIC ACID; 6 [2 [1 METHYL 1 (2 NITRO 4 TOLYLOXY)ETHYL] 4 (3 PYRIDYL) 1,3 DIOXAN 5 YL] 4 HEXENOIC ACID; 6,8 DIFLUORO 1,2,3,4 TETRAHYDRO 9 (4 METHYLSULFONYLBENZYL)CARBAZOLE 1 ACETIC ACID; 7 [3 [(4 PHENYLSEMICARBAZIDO)METHYL] 7 OXABICYCLO[2.2.1]HEPT 2 YL] 5 HEPTENOIC ACID; DALTROBAN; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); PROSTANOID RECEPTOR; PROSTANOID TP RECEPTOR; THROMBOXANE RECEPTOR BLOCKING AGENT; THROMBOXANE RECEPTOR STIMULATING AGENT; UNCLASSIFIED DRUG; VAPIPROST;

ARTICLE; COMPETITIVE INHIBITION; CONTROLLED STUDY; DISSOCIATION CONSTANT; DRUG POTENCY; DRUG RECEPTOR BINDING; FEMALE; HUMAN; HUMAN TISSUE; MYOMETRIUM; PRIORITY JOURNAL; UTERUS CONTRACTION;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ADULT; BICYCLO COMPOUNDS, HETEROCYCLIC; BINDING, COMPETITIVE; DOSE-RESPONSE RELATIONSHIP, DRUG; FATTY ACIDS, UNSATURATED; FEMALE; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); HUMANS; MIDDLE AGED; MYOMETRIUM; PROSTAGLANDIN ENDOPEROXIDES, SYNTHETIC; RECEPTORS, THROMBOXANE; THROMBOXANE A2;

EID: 0030439227     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. ARMSTRONG, R. A., HUMPHREY, P. P. A. AND LUMLEY, P.: Reduction in the number of thromboxane receptors on human platelets after exposure to GR32191. Br. J. Pharmacol. 110: 548-552, 1993.
2. BRADFORD, M. M.: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254, 1976.
3. 2) synthase inhibitor and receptor antagonist. Br. J. Pharmacol. 107S: 129P, 1992.
4. 2 receptor antagonists. Thromb. Res. 44: 377-389, 1986.
5. CHEUK, J. M. S., HOLLINGSWORTH, M., HUGHES, S. J., PIPER, I. T. AND MARESH, M. J. A.: Inhibition of contractions of the isolated human myometrium by potassium channel openers. Am. J. Obstet. Gynecol. 168: 953-960, 1993.
6. CLAYTON, J. K., MARSHALL, K., SANGHA, R., SENIOR, J. AND GARDINER, P. J.: Thromboxane receptor blockade and the isolated human myometrium. Abstracts from 7th International Conference on Prostaglandins and Related Compounds, Florence, Italy, p. 153, 1990.
7. 2 on some isolated smooth muscle preparations. Br. J. Pharmacol. 73: 773-778, 1981.
8. COLEMAN, R. A., SMITH, W. L. AND NARUMIYA, S.: International Union of Pharmacology Classification of Prostanoid Receptors: Properties, distribution, and structure of the receptors and their subtypes. Pharmacol. Rev. 46: 205-229, 1994.
9. CRANKSHAW, D. J.: Myometrial contractility in vitro: Its role in an understanding of the mechanisms controlling uterine activity. In Uterine Contractility, ed. by R. E. Garfield, pp. 85-101, Serono Symposium, Massachusetts, 1990.
10. CRANKSHAW, D. J.: Variability in the response of the human uterus in vitro to thromboxane mimetics. Abstracts from 8th International Conference on Prostaglandins and Related Compounds, Montreal, Canada, p. 65, 1992.
11. 2α on the contractility of the human myometrium in vitro. Eur. J. Pharmacol. 285: 151-158, 1995.
12. CRANKSHAW, D. J., CRANKSHAW, J., BRANDA, L. A. AND DANIEL, E. E.: Receptors for E type prostaglandins in the plasma membrane of nonpregnant human myometrium. Arch. Biochem. Biophys. 198: 70-77, 1979.
13. CRANKSHAW, D. J. AND DYAL, R.: Effects of some naturally occurring prostanoids and some cyclooxygenase inhibitors on the contractility of the human lower uterine segment in vitro. Can. J. Physiol. Pharmacol. 72: 870-874, 1994.
14. 2 receptor from K562 (human chronic myelogenous leukemia) cells. J. Pharmacol. Exp. Ther. 271: 1034-1041, 1994.
15. 2 receptor antagonists. Ad. Drug Res. 25: 173-202, 1994.
16. 2 receptor subtypes. A radioligand binding study of human platelets. J. Clin. Invest. 84: 1883-1891, 1989.
17. 2 receptors. Am. J. Physiol. 261: R145-R153, 1991.
18. DYAL, R. AND CRANKSHAW, D. J.: The effects of some synthetic prostanoids on the contractility of the human lower uterine segment in vitro. Am. J. Obstet. Gynecol. 158: 281-285, 1988.
19. FORD-HUTCHINSON, A. W., GIRARD, Y., LORD, A., JONES, T. R., CIRINO, M., EVANS, J. F., GILLARD, J., HAMEL, P., LEVEILLE, C., MASSON, P. AND YOUNG, R.: The pharmacology of L-670,596, a potent and selective thromboxane/prostaglandin endoperoxide receptor antagonist. Can. J. Pharmacol. 67: 989-993, 1989.
20. HAMBERG, M., SVENSSON, J. AND SAMUELSSON, B.: Thromboxanes: A new group of biologically active compounds derived from prostaglandin endoperoxides. Proc. Natl. Acad. Sci. U.S.A. 72: 2994-2998, 1975.
21. 2 receptor. Nature 349: 617-620, 1991.
22. HOFER, G., BIEGLMAYEH, C., KOPP, B. AND JANISCH, H.: Measurement of eicosanoids in menstrual fluid by the combined use of high pressure chromatography and radioimmunoassay. Prostaglandins 45: 413-426, 1993.
23. HULME, E. C. AND BIRDSALL, N. J. M.: Strategy and tactics in receptor-binding studies. In Receptor-Ligand Interaction. A Practical Approach, ed. by E. C. Hulme, pp. 63-176, Oxford University Press, New York, 1992.
24. 2 receptor antagonist, on platelets. Br. J. Pharmacol. 95S: 676P, 1988.
25. KENAKIN, T. P.: The classification of drugs and drug receptors in isolated tissues. Pharmacol. Rev. 36: 165-222, 1984.
26. 2/prostaglandin endoperoxide receptor, on platelet aggregation and thrombosis. Eur. J. Pharmacol. 163: 253-261, 1989.
27. 2 receptor blocking drug on platelets and vascular and airways smooth muscle in vitro. Br. J. Pharmacol. 97: 783-794, 1989.
28. 2 receptors. Evidence for different subclasses in the rat. Biochem. Pharmacol. 42: 537-544, 1991.
29. 2 receptor agonist. J. Pharmacol. Exp. Ther. 251: 557-562, 1989.
30. 2 receptors in human vascular smooth muscle cells. Life Sci. 46: 1765-1772, 1990a.
31. 2 mimetic, I-BOP. Adv. Prost. Throm. Leuk. Res. 21: 331-337, 1990b.
32. MUNSON, P. J. AND RODBARD, D.: Ligand: A versatile computerized approach for the characterization of ligand-binding systems. Anal. Biochem. 107: 220-239, 1980.
33. NEEDLEMAN, P., MINKES, M. AND RAZ, A.: Thromboxanes: Selective biosynthesis and distinct biological properties. Science 193: 163-165, 1976.
34. 2 receptor gene. J. Biol. Chem. 268: 25253-25259, 1993.
35. OGLETREE, M. L. AND ALLEN, G. T.: Interspecies differences in thromboxane receptors: Studies with thromboxane receptor antagonists in rat and guinea pig smooth muscles. J. Pharmacol. Exp. Ther. 260: 789-794, 1992.
36. OGLETREE, M. L., HARRIS, D. N., GREENBERG, R., HASLANGER, M. F. AND NAKANE, M.: Pharmacological actions of SQ 29,548, a novel selective thromboxane antagonist. J. Pharmacol. Exp. Ther. 234: 435-441, 1985.
37. PLIŠKA, V.: Models to explain dose-response relationships that exhibit a downturn phase. TIPS 15: 178-181, 1994.
38. POLLOCK, W. K., ARMSTRONG, R. A., BRYDON, L. J., JONES, R. L. AND MACINTYRE, D. E.: Thromboxane-induced phosphatidate formation in human platelets. Relationship to receptor occupancy and to changes in cytosolic free calcium. Biochem. J. 219: 833-842, 1984.
39. 2 receptor. J. Biol. Chem. 269: 19256-19261, 1994.
40. 2 receptor in guinea pig lung membranes using a radioiodinated thromboxane mimetic. Mol. Pharmacol. 39: 72-78, 1991.
41. SENIOR, J., SANGHA, R., BAXTER, G. S., MARSHALL, K. AND CLAYTON, J. K.: In vitro characterization of prostanoid FP-, DP-, IP- and TP-receptors on the nonpregnant human myometrium. Br. J. Pharmacol. 107: 215-221, 1992.
42. SENIOR, J., MARSHALL, K., SANGHA, R. AND CLAYTON, K. K.: In vitro characterization of prostanoid receptors on human myometrium at term pregnancy. Br. J. Pharmacol. 108: 501-506, 1993.
43. 3H]histamine. Biochemistry 24: 6095-6107, 1985.
44. 2 receptor gene in human uterus. Biol. Reprod. 47: 105-117, 1992.
45. SZABADI, E.: A model of two functionally antagonistic receptor populations activated by the same agonist. J. Theor. Biol. 69: 101-112, 1977.
46. 2α, in the rat. J. Clin. Invest. 90: 136-141, 1992.
47. WAINMAN, B. C., BURCEA, I. AND CRANKSHAW, D. J.: The effects of prostanoids on estrogen-dominated rat myometrial longitudinal muscle in vitro. Biol. Reprod. 39: 221-228, 1988.